TAM
BIO icon

THB Asset Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

THB Asset Management’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-7,665
Closed -$1.04M – 218
2015
Q1 		$1.04M Sell
7,665
-19,110
-71% -$2.37M 0.07% 223
2014
Q4 		$3.23M Sell
26,775
-299
-1% -$34.4K 0.21% 155
2014
Q3 		$3.07M Sell
27,074
-8,820
-25% -$1.05M 0.21% 153
2014
Q2 		$4.3M Sell
35,894
-102
-0.3% -$12.5K 0.27% 138
2014
Q1 		$4.61M Sell
35,996
-10,012
-22% -$1.28M 0.28% 143
2013
Q4 		$5.69M Sell
46,008
-1,602
-3% -$195K 0.31% 130
2013
Q3 		$5.6M Buy
47,610
+3,450
+8% +$407K 0.35% 125
2013
Q2 		$4.95M Buy
+44,160
New +$5.18M 0.33% 133

Other funds holding BIO

ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.31B AUM 28.11% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $501B AUM 22.01% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return